Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hantech Bio-Technology CoROCO:1294 74 Days Payable is 67.52 as of Dec. 2025, which is 18% above its 10-year median of 57.11. GuruFocus rates ROCO:1294 with a GF Score™ of 74/100 and a GF Value™ of NT$77.04 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 1,890 Consumer Packaged Goods companies, Hantech Bio-Technology Co ranks better than 65.93% on this metric.
The historical rank and industry rank for Hantech Bio-Technology Co's Days Payable or its related term are showing as below:
ROCO:1294'
s Days Payable Range Over the Past 10 Years
Min: 35.75 Med: 57.11 Max: 70.43
Current: 60.89
During the past 7 years, Hantech Bio-Technology Co's highest Days Payable was 70.43. The lowest was 35.75. And the median was 57.11.
ROCO:1294's Days Payable is ranked better than 65.93% of 1890
companies
in the Consumer Packaged Goods industry
Industry Median: 44.145
vs ROCO:1294: 60.89
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Hantech Bio-Technology Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hantech Bio-Technology Co Days Payable vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Hantech Bio-Technology Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Hantech Bio-Technology Co's Days Payable falls into.
Hantech Bio-Technology Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Hantech Bio-Technology Co's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hantech Bio-Technology Co (ROCO:1294) has a Days Payable of 67.52 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Hantech Bio-Technology Co and its competitors. This is 18% above median its historical median of 57.11. Over the past decade, Hantech Bio-Technology Co's Days Payable has ranged from 35.75 to 70.43. According to the industry distribution chart, Hantech Bio-Technology Co ranks #644 out of 1890 companies in the Consumer Packaged Goods industry, placing it in the top 34.1%.
Is Hantech Bio-Technology Co's Days Payable too high?
Hantech Bio-Technology Co's current Days Payable of 67.52 is 18% above median its 10-year median of 57.11. Over the past 10 years, this metric has ranged from a low of 35.75 to a high of 70.43. The Consumer Packaged Goods industry median Days Payable is 44.15. Hantech Bio-Technology Co's value of 67.52 is 53% above this industry median. Based on the distribution chart, Hantech Bio-Technology Co ranks #644 out of 1890 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Hantech Bio-Technology Co has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hantech Bio-Technology Co's Days Payable compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Hantech Bio-Technology Co ranks #644 out of 1890 companies for Days Payable. This puts Hantech Bio-Technology Co in the upper half of its industry. The industry median Days Payable is 44.15. Hantech Bio-Technology Co's value of 67.52 is 53% above this benchmark. Historically, Hantech Bio-Technology Co's own Days Payable has ranged from 35.75 to 70.43 over the past decade. While the company's 10-year median is 57.11 vs. the industry median of 44.15, Hantech Bio-Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Consumer Packaged Goods company?
The median Days Payable among Consumer Packaged Goods companies is 44.15, based on 1,890 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hantech Bio-Technology Co's current Days Payable of 67.52 is 53% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Hantech Bio-Technology Co and its competitors. For the Consumer Packaged Goods industry, the median Days Payable is 44.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hantech Bio-Technology Co's current Days Payable is 67.52, which is 18% above median its own 10-year median of 57.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hantech Bio-Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Hantech Bio-Technology Co (ROCO:1294) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$77.04, compared to a current price of NT$57.50 — trading 25.4% below its estimated fair value. The current Days Payable is 67.52, which is 18% above median its 10-year median of 57.11 and 53% above the Consumer Packaged Goods industry median of 44.15. Hantech Bio-Technology Co's overall GF Score™ is 74/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Hantech Bio-Technology Co (ROCO:1294), the current Days Payable is 67.52 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hantech Bio-Technology Co (ROCO:1294) Overvalued in 2026?
Based on GuruFocus' analysis, Hantech Bio-Technology Co stock appears to be undervalued.
The current stock price of NT$57.50 is trading 25.4% below its estimated GF Value™ of NT$77.04.
GuruFocus considers Hantech Bio-Technology Co to be Modestly Undervalued.
Key valuation signals for ROCO:1294:
Days Payable: 67.52 (18% above median its 10-year median of 57.11)
GF Value™: NT$77.04 vs. price of NT$57.50 (25.4% below fair value)
Industry Position: 53% above the Consumer Packaged Goods median (#644 of 1890)
No single metric tells the full story. See the ROCO:1294 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hantech Bio-Technology Co Ltd mainly engaged in the manufacture, trading, and agency of biotech foods, health foods, and Traditional Chinese Medicine skincare and beauty products.
74GF Score
Get the complete analysis for ROCO:1294
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:1294 has been successfully added to your 
